References
- World Health Organization. Geneva: World Health Organization [Internet]. 2023. Epilepsy fact sheet.
- Mohammadzadeh P, Nazarbaghi S. The prevalence of drug-resistant-epilepsy and its associated factors in patients with epilepsy. Clin Neurol Neurosurg [Internet]. 2022;213:107086. Available from: https://www.sciencedirect.com/science/article/pii/S0303846721006156
- Perucca E, Cloyd J, Critchley D, Fuseau E. Rufinamide: clinical pharmacokinetics and concentration–response relationships in patients with epilepsy. Epilepsia. 2008;49(7):1123–41.
- Schmutz M, Allgeier H, Jeker A, Klebs K, McLean MJ, Mondadori C, et al. Anticonvulsant profile of CGP 33101 in animals. Epilepsia. 1993;34(Suppl 2):122.
- Mazzucchelli I, Rapetti M, Fattore C, Franco V, Gatti G, Perucca E. Development and validation of an HPLC–UV detection assay for the determination of rufinamide in human plasma and saliva. Anal Bioanal Chem. 2011;401:1013–21.
- Heaney D, Walker MC. Rufinamide. Drugs Today (Barc). 2007;43(7):455–60.
- Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications. Int J Pharm. 2007;329(1–2):1–11.
- Hirayama F, Uekama K. Cyclodextrin-based controlled drug release system. Adv Drug Deliv Rev [Internet]. 1999;36(1):125–41. Available from: https://www.sciencedirect.com/science/article/pii/S0169409X98000581
- Szabó ZI, Gál R, Gáll Z, Vancea S, Rédai E, Fülöp I, et al. Cyclodextrin complexation improves aqueous solubility of the antiepileptic drug, rufinamide: solution and solid state characterization of compound-cyclodextrin binary systems. J Incl Phenom Macrocycl Chem. 2017 Jun 1;88(1–2):43–52.
- Heinemann UWE, Kann O, Schuchmann S. An overview of in vitro seizure models in acute and organotypic slices. Models of seizures and epilepsy. 2006;35–44.
- Samiee S, Baillet S. Time-resolved phase-amplitude coupling in neural oscillations. Neuroimage. 2017;159:270–9.
- Zhang ZJ, Koifman J, Shin DS, Ye H, Florez CM, Zhang L, et al. Transition to seizure: Ictal discharge is preceded by exhausted presynaptic GABA release in the hippocampal CA3 region. Journal of Neuroscience. 2012;32(7).
- Tadel F, Baillet S, Mosher JC, Pantazis D, Leahy RM. Brainstorm: A User-Friendly Application for MEG/EEG Analysis. Oostenveld R, editor. Comput Intell Neurosci [Internet]. 2011;2011:879716. Available from: https://doi.org/10.1155/2011/879716
- Gáll Z, Orbán-Kis K, Szilágyi T. Differential effects of sodium channel blockers on in vitro induced epileptiform activities. Arch Pharm Res. 2017 Jan 1;40(1):112–21.
- Niespodziany I, Leclère N, Vandenplas C, Foerch P, Wolff C. Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation. J Neurosci Res. 2013;91(3):436–43.
- Marafiga JR, Pasquetti MV, Calcagnotto ME. In vitro oscillation patterns throughout the hippocampal formation in a rodent model of epilepsy. Neuroscience. 2021;479:1–21.
- Johnson NW, Özkan M, Burgess AP, Prokic EJ, Wafford KA, O’Neill MJ, et al. Phase-amplitude coupled persistent theta and gamma oscillations in rat primary motor cortex in vitro. Neuropharmacology. 2017;119:141–56.